ReviewLancet (London, England)2023
The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
Abstract readReview
In one paragraph
Review in Lancet (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Clinician Prompts for Human Papillomavirus Vaccination: A Cluster Randomized Trial.Academic pediatricsTrial
- The Impact of the Coronavirus Disease 2019 Pandemic on Parental Childhood Vaccine Attitudes in the United States.Academic pediatrics · 2025Review
- Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.Lancet (London, England) · 2025Article
- Parental Barriers and Sociodemographic Disparities in Childhood Vaccination Post-COVID-19 in Tennessee.Vaccines · 2025Article
- Proceedings of the second annual dengue endgame summit: A call to action.PLoS neglected tropical diseases · 2025Article
- Parents' Attitudes About Childhood Vaccines Before and After the COVID-19 Pandemic: A Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2025Article
- Microbes Saving Lives and Reducing Suffering.Microbial biotechnology · 2025Article
- No negative effect of mentioning COVID-19 vaccine in influenza vaccine encouragements: Evidence from a survey experiment.PLOS global public health · 2025Article
- Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity.Journal of medical virology · 2024Observational
- An Experimental Study on how Messaging from CDC Affects Attitudes toward Mandatory MMR Vaccination for Schoolchildren.Journal of community health · 2024Article
- "Do not inject our babies": a social listening analysis of public opinion about authorizing pediatric COVID-19 vaccines.Health affairs scholar · 2024Article
- Article
- Spillover effects of the COVID-19 pandemic on attitudes to influenza and childhood vaccines.BMC public health · 2023Article
- COVID-19 Vaccine Hesitancy among New Jersey Teachers and Impacts of Vaccination Information Dissemination.Vaccines · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Douglas J OpelDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA. Electronic address: douglas.opel@seattlechildrens.org.
Noel T BrewerDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Alison M ButtenheimDepartment of Family and Community Health, University of Pennsylvania School of Nursing and Center for Health Incentives, University of Pennsylvania, Philadelphia, PA, USA; Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.
Timothy CallaghanDepartment of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA.
Richard M CarpianoSchool of Public Policy, University of California, Riverside, CA, USA.
Chelsea ClintonClinton Foundation, New York, NY, USA; Mailman School of Public Health, Columbia University, New York, NY, USA.
Jad A ElharakeYale Institute for Global Health, New Haven, CT, USA; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA.
Lisa C FlowersDepartment of Obstetrics & Gynecology, Emory University, Atlanta, GA, USA.
Alison P GalvaniCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
Peter J HotezTexas Children's Center for Vaccine Development, Baylor College of Medicine, Houston, TX, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; Hagler Institute for Advanced Study, Texas A&M University, College Station, TX, USA; Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA; James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA.
Jason L SchwartzDepartment of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
Regina M BenjaminGulf States Health Policy Center, Bayou La Batre, AL, USA.
Arthur CaplanNew York University Langone School of Medicine, New York University, New York, NY, USA.
Renee DiRestaStanford Internet Observatory, Stanford University, Stanford, CA, USA.
Rekha LakshmananThe Immunization Partnership, Houston, TX, USA.
Yvonne A MaldonadoStanford University School of Medicine, Stanford, CA, USA.
Michelle M MelloFreeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA; Stanford Law School, Stanford, CA, USA; Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA.
Wendy E ParmetCenter for Health Policy & Law, Northeastern University, Boston, MA, USA.
Daniel A SalmonInstitute for Vaccine Safety, Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Joshua M SharfsteinDepartment of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Saad B OmerYale Institute for Global Health, New Haven, CT, USA; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Yale School of Nursing, Orange, CT, USA.
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MNCATS NIH HHS UL1 TR001863
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19HumansPandemicsUnited StatesVaccination
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.